What was Burzynski Research Institute’s price range in the past 12 months?
Burzynski Research Institute lowest stock price was $0.01 and its highest was $0.06 in the past 12 months.
What is Burzynski Research Institute’s market cap?
Burzynski Research Institute’s market cap is $26.29K.
When is Burzynski Research Institute’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Burzynski Research Institute overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Burzynski Research Institute pay dividends?
Burzynski Research Institute does not currently pay dividends.
What is Burzynski Research Institute’s EPS estimate?
Burzynski Research Institute’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Burzynski Research Institute have?
Burzynski Research Institute has 131,448,440 shares outstanding.
Which hedge fund is a major shareholder of Burzynski Research Institute?
Currently, no hedge funds are holding shares in BZYR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Burzynski Research Institute
Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. The company was founded in 1977 and is headquartered in Houston, Texas.